CABA

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Asthma1 trial
• Chronic spontaneous urticaria1 trial
• COPD1 trial
• Ulcerative colitis1 trial

Phase

• Phase 23 trials
• Phase 31 trial

Status

• Completed3 trials
• Active, not recruiting1 trial

Lead sponsor

• Sanofi4 trials

Running trials

• Active, not recruiting

  Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis

  NCT05588843· Phase 2· Sanofi· Source

Closed trials

• Completed

  Proof of Concept Study of Rilzabrutinib in Adult Participants With Moderate-to-severe Asthma

  NCT05104892· Phase 2· Sanofi· Source

• Completed

  Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine

  NCT05107115· Phase 2· Sanofi· Source

• Completed

  Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation

  NCT04456673· Phase 3· Sanofi· Source